222 related articles for article (PubMed ID: 11112391)
1. Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura.
Stasi R; Brunetti M; Pagano A; Stipa E; Masi M; Amadori S
Blood Cells Mol Dis; 2000 Dec; 26(6):582-6. PubMed ID: 11112391
[TBL] [Abstract][Full Text] [Related]
2. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
3. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy.
Andersen JC
N Engl J Med; 1994 Jun; 330(22):1560-4. PubMed ID: 8177245
[TBL] [Abstract][Full Text] [Related]
4. Experience with high dose dexamethasone in the treatment of chronic symptomatic immune thrombocytopaenia.
Van Riet FA; Wessels G; Hesseling PB
East Afr Med J; 1999 Oct; 76(10):571-4. PubMed ID: 10734508
[TBL] [Abstract][Full Text] [Related]
5. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Cheng Y; Wong RS; Soo YO; Chui CH; Lau FY; Chan NP; Wong WS; Cheng G
N Engl J Med; 2003 Aug; 349(9):831-6. PubMed ID: 12944568
[TBL] [Abstract][Full Text] [Related]
6. [Pulsed high-dose dexamethasone in resistant immune thrombocytopenic purpura].
Bulvik S; Ben-Tal O; Shimoni Z; Eldor A
Harefuah; 1996 Jul; 131(1-2):18-20, 71. PubMed ID: 8854471
[TBL] [Abstract][Full Text] [Related]
7. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults.
Borst F; Keuning JJ; van Hulsteijn H; Sinnige H; Vreugdenhil G
Ann Hematol; 2004 Dec; 83(12):764-8. PubMed ID: 15309522
[TBL] [Abstract][Full Text] [Related]
8. [Rituximab treatment of chronic idiopathic thrombocytopenic purpura. Results of a phase II study].
Meo P; Stipa E; La Presa M; Bianchi M; Di Giulio C; Stasi R; Amadori S
Recenti Prog Med; 2002; 93(7-8):421-7. PubMed ID: 12138687
[TBL] [Abstract][Full Text] [Related]
9. Effect of high-dose dexamethasone in prednisone-resistant autoimmune thrombocytopenic purpura (ITP).
Dubbeld P; van der Heul C; Hillen HF
Neth J Med; 1991 Aug; 39(1-2):6-10. PubMed ID: 1961352
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
[TBL] [Abstract][Full Text] [Related]
12. Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome.
Ling Y; Cao X; Yu Z; Ruan C
Eur J Haematol; 2007 Oct; 79(4):310-6. PubMed ID: 17692100
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
Ramadan KM; El-Agnaf M
Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
[TBL] [Abstract][Full Text] [Related]
15. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F
Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
17. High-dose cycles of dexamethasone in idiopathic thrombocytopenic purpura.
Calabresi AR; Veith RW; Rigby PG
J La State Med Soc; 2004; 156(5):269-72. PubMed ID: 15554097
[TBL] [Abstract][Full Text] [Related]
18. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Schweizer C; Reu FJ; Ho AD; Hensel M
Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
[TBL] [Abstract][Full Text] [Related]
19. Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults--a report on 90 patients.
Damodar S; Viswabandya A; George B; Mathews V; Chandy M; Srivastava A
Eur J Haematol; 2005 Oct; 75(4):328-31. PubMed ID: 16146539
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.
Cooper N; Stasi R; Cunningham-Rundles S; Feuerstein MA; Leonard JP; Amadori S; Bussel JB
Br J Haematol; 2004 Apr; 125(2):232-9. PubMed ID: 15059147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
